Refeyn introduces new mass photometry products to streamline biomolecular analysis workflows

Refeyn, the company behind pioneering mass photometry technologies, has taken another step to assure mass photometry is a simpler, more efficient bioanalytics tool with the release of a powerful expansion of its consumables portfolio.

COVID-19 severity linked to autoantibodies against blood clotting protein

Study investigates the occurrence of ADAMTS13 antibodies in COVID-19 patients and their association with disease severity and lower ADAMTS13 activity. The findings suggest the need

July 3, 2023

The Dangers of Ketamine Revisited

As most people know by now, ketamine clinics are prevalent in the United States. These clinics offer ketamine as a treatment for a variety of

January 11, 2024

KU researcher awarded $4.2 million grant to address eating disorders in active-duty military members

A University of Kansas researcher who developed the first screening tool for eating disorders in veterans has been awarded a four-year, $4.2 million grant by

June 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.